Cisplatin Plus Vinorelbine With or Without Tirapazamine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Part of paid clinical trials in Los Angeles, California.

Sponsor
Sanofi
Study ID
NCT00017459
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if cisplatin and vinorelbine are more effective with or without tirapazamine in treating non-small cell lung cancer PURPOSE: Randomized phase III trial to compare the effectiveness of cisplatin plus vinorelbine with or without tirapazamine in treating patients who have stage IIIB or stage IV non-small cell lung cancer.

Key Dates

Start date
Jul 31, 2000
Status verified
Feb 2010
Completion
Feb 29, 2004

Study Design

Primary purpose
TREATMENT

Locations (42)

FacilityCityStateZIPSite coordinators
Medical Oncology Internal MedicineLos AngelesCalifornia90067-
Tower Hematology Oncology Medical GroupLos AngelesCalifornia90048-
Bay Area Tumor InstituteOaklandCalifornia94609-
Medical Oncology Care AssociatesOrangeCalifornia92668-
UCSF Cancer Center and Cancer Research InstituteSan FranciscoCalifornia94143-0128-
John Wayne Cancer InstituteSanta MonicaCalifornia90404-
Los Angeles County Harbor-UCLA Medical CenterTorranceCalifornia90509-
Medical Oncology-Hematology Consultants, P.A.WilmingtonDelaware19808-
Veterans Affairs Medical Center - Washington, DCWashington D.C.District of Columbia20422-
Washington Cancer InstituteWashington D.C.District of Columbia20010-
University of Florida Health Science Center - JacksonvilleJacksonvilleFlorida32209-
Watson ClinicLakelandFlorida33804-5000-
Ocala Oncology CenterOcalaFlorida34474-
Ocala Research Institute, IncOcalaFlorida34471-
Saint Alphonsus Regional Medical CenterBoiseIdaho83706-
Dreyer Medical ClinicAuroraIllinois60506-
University of Chicago Cancer Research CenterChicagoIllinois60637-1470-
Northwest Oncology and Hematology, S.C.Elk Grove VillageIllinois60007-
Rockford ClinicRockfordIllinois61103-
Cancer Care CenterNew AlbanyIndiana47150-
CCOP - Northern Indiana CR ConsortiumSouth BendIndiana46601-
Hematology-Oncology ClinicBaton RougeLouisiana70808-
University of Minnesota Cancer CenterMinneapolisMinnesota55455-
Capitol Comprehensive Cancer Care ClinicJefferson CityMissouri65109-
Veterans Affairs Medical Center - Kansas CityKansas CityMissouri64128-
St. John's Mercy Medical CenterSt LouisMissouri63141-
Western Montana ClinicMissoulaMontana59803-
Veterans Affairs Medical Center - East OrangeEast OrangeNew Jersey07018-1095-
Brookdale University Hospital and Medical CenterBrooklynNew York11212-
Interlakes Oncology/Hematology PCRochesterNew York14623-
New York Medical CollegeValhallaNew York10595-
Akron General Medical CenterAkronOhio44302-
Cleveland Clinic Taussig Cancer CenterClevelandOhio44195-
North Penn HospitalLansdalePennsylvania19446-1200-
Fox Chase - Temple Cancer CenterPhiladelphiaPennsylvania19140-
Lone Star OncologyAustinTexas78759-
Center for Oncology Research and Treatment, Medical City HospitalDallasTexas75230-
Southwest Cancer Center at University Medical CenterLubbockTexas79415-
Baptist Health System Cancer ProgramSan AntonioTexas78205-
Cancer Therapy Research CenterSan AntonioTexas78229-
Veterans Affairs Medical Center - TempleTempleTexas76504-
Arlington-Fairfax Hematology/Oncology, PCArlingtonVirginia22205-

Find similar trials in Los Angeles, CA

By condition

Related Studies